BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

775 related articles for article (PubMed ID: 27938677)

  • 21. Control and eradication of Brucella melitensis infection in sheep and goats.
    Blasco JM; Molina-Flores B
    Vet Clin North Am Food Anim Pract; 2011 Mar; 27(1):95-104. PubMed ID: 21215893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response and antigen-specific gamma-interferon profiles of vaccinated and unvaccinated pregnant sheep experimentally infected with Brucella melitensis.
    Durán-Ferrer M; Léon L; Nielsen K; Caporale V; Mendoza J; Osuna A; Perales A; Smith P; De-Frutos C; Gómez-Martín B; Lucas A; Chico R; Delgado OD; Escabias JC; Arrogante L; Díaz-Parra R; Garrido F
    Vet Microbiol; 2004 Jun; 100(3-4):219-31. PubMed ID: 15145500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Field-oriented trial of the Chinese Brucella suis strain 2 vaccine on sheep and goats in Libya.
    Mustafa AA; Abusowa M
    Vet Res; 1993; 24(5):422-9. PubMed ID: 8260964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel vector vaccine against Brucella abortus based on influenza A viruses expressing Brucella L7/L12 or Omp16 proteins: evaluation of protection in pregnant heifers.
    Tabynov K; Yespembetov B; Sansyzbay A
    Vaccine; 2014 Oct; 32(45):5889-92. PubMed ID: 25218295
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaccination of goats with a combination
    Leya M; Kim WK; Cho JS; Yu EC; Kim YJ; Yeo Y; Lyoo KS; Yang MS; Han SS; Lee JH; Tark D; Hur J; Kim B
    J Vet Sci; 2018 Sep; 19(5):643-652. PubMed ID: 29929362
    [No Abstract]   [Full Text] [Related]  

  • 26. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of novel Brucella melitensis unmarked deletion mutants for safety and efficacy in the goat model of brucellosis.
    Kahl-McDonagh MM; Elzer PH; Hagius SD; Walker JV; Perry QL; Seabury CM; den Hartigh AB; Tsolis RM; Adams LG; Davis DS; Ficht TA
    Vaccine; 2006 Jun; 24(24):5169-77. PubMed ID: 16697090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination control programs for multiple livestock host species: an age-stratified, seasonal transmission model for brucellosis control in endemic settings.
    Beauvais W; Musallam I; Guitian J
    Parasit Vectors; 2016 Jan; 9():55. PubMed ID: 26825313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of humoral and cellular immune responses to BP26 and OMP31 epitopes in the attenuated Brucella melitensis vaccinated sheep.
    Wang W; Wu J; Qiao J; Weng Y; Zhang H; Liao Q; Qiu J; Chen C; Allain JP; Li C
    Vaccine; 2014 Feb; 32(7):825-33. PubMed ID: 24370708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic diversity of Brucella abortus and Brucella melitensis in Kazakhstan using MLVA-16.
    Shevtsov A; Ramanculov E; Shevtsova E; Kairzhanova A; Tarlykov P; Filipenko M; Dymova M; Abisheva G; Jailbekova A; Kamalova D; Chsherbakov A; Tulegenov S; Akhmetova A; Sytnik I; Karibaev T; Mukanov K
    Infect Genet Evol; 2015 Aug; 34():173-80. PubMed ID: 26160544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous subcutaneous and conjunctival administration of the influenza viral vector based Brucella abortus vaccine to pregnant heifers provides better protection against B. abortus 544 infection than the commercial B. abortus S19 vaccine.
    Tabynov K; Orynbayev M; Renukaradhya GJ; Sansyzbay A
    Vaccine; 2016 Sep; 34(42):5049-5052. PubMed ID: 27595898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimen.
    Golshani M; Rafati S; Siadat SD; Nejati-Moheimani M; Shahcheraghi F; Arsang A; Bouzari S
    Mol Immunol; 2015 Aug; 66(2):384-91. PubMed ID: 25968974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of immune responses in mice and sheep inoculated with a live attenuated Brucella melitensis REV1 vaccine produced in bioreactor.
    Curina G; Nardini R; Corneli S; D'Avino N; Tentellini M; Montagnoli C; Severi G; Forti K; Paternesi B; Coletti M; Cagiola M
    Vet Immunol Immunopathol; 2018 Apr; 198():44-53. PubMed ID: 29571517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMMUNIZATION AGAINST BRUCELLA INFECTION. 10. THE RELATIVE IMMUNOGENICITY OF BRUCELLA ABORTUS STRAIN 19-BA AND BRUCELLA MELITENSIS STRAIN REV I IN CYNOMOLGUS PHILIPPINENSIS.
    ELBERG SS; FAUNCE WK
    Bull World Health Organ; 1964; 30(5):693-9. PubMed ID: 14196815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serological findings obtained in cattle herds immunised with the Brucella melitensis Rev.1 and the B. abortus B19 vaccine in Mongolia.
    Dénes B
    Acta Vet Hung; 1997; 45(1):33-43. PubMed ID: 9270127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative analysis of Brucella serotype A and M and Yersinia enterocolitica O:9 polysaccharides for serological diagnosis of brucellosis in cattle, sheep, and goats.
    Díaz-Aparicio E; Aragón V; Marín C; Alonso B; Font M; Moreno E; Pérez-Ortiz S; Blasco JM; Díaz R; Moriyón I
    J Clin Microbiol; 1993 Dec; 31(12):3136-41. PubMed ID: 8308104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
    Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.